Neuromodulation for the Treatment of Fecal Incontinence

Mitchell Bernstein, MD
NYU Langone Medical Center
New York, NY

Didactic Lecture

Viewing Options

Webcast

Topic Information

Target Audience

This enduring activity has been designed to meet the educational needs of gastroenterologists, colorectal surgeons, urogynecologists, physician assistants, nurse practitioners and nurses involved in the care of patients with fecal incontinence.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Understand the mechanism of action of sacral nerve stimulation in the management of fecal incontinence

Describe the procedures for the test stimulation and chronic implantation phases of the sacral nerve stimulator

Summarize evidence regarding the safety and efficacy of sacral nerve modulation in patients with chronic fecal incontinence

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Gi Health Foundation.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: February 23, 2015Expiration Date: February 23, 2016  
*This program has expired. CME credit is no longer available.

Faculty Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education (ACHS), consults for Pfizer, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and The Gi Health Foundation has no relationships to disclose.

Faculty Disclosure Statement

Consultant/ Speaker Bureau: Salix Pharmaceuticals, Inc.

This program is supported by an Educational grant from Salix Pharmaceuticals, Inc.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.